Replies to post #6525 on GTC Biotherapeutics (fka GTCB)

[gym gravity]

"The restriction of efficacy events to symptomatic DVT rather than any DVT lessens the variability of the outcomes in both arms and thereby makes a finding of non-inferiority more likely."

and makes for a cheaper trial.